期刊文献+

新型内皮素受体拮抗剂CPU0214与正常大鼠心肌ET受体结合特点及对清醒DOCA-盐型高血压大鼠的降压作用 被引量:3

Antagonistic effects of new endothelin antagonist CPU0214 on cardiac endothelin receptor binding and vascular activity and its reduction on mean arterial pressure in conscious DOCA-salt hypertensive rats
暂未订购
导出
摘要 目的 研究新型内皮素受体拮抗剂CPU0 2 1 4与正常大鼠心肌内皮素 (ET)受体结合特点 ,对血管收缩的拮抗作用及对高血压大鼠血压的降低作用。方法 采用放射配体竞争抑制结合法和ET 1引起的胸主动脉环收缩法分别研究CPU0 2 1 4与正常大鼠心肌ET受体结合的特性和对血管收缩功能的拮抗作用 ;采用放射配体结合法观察注射醋酸脱氧皮质酮 (DO CA)和饮用盐水造成的高血压模型大鼠的心肌ET受体的改变及其股动脉平均动脉压的变化 ,研究CPU0 2 1 4的降压作用。结果 CPU0 2 1 4在正常心肌膜上竞争性结合1 2 5I ET1 ,其IC50 为1 6nmol·L-1 ;抑制ET 1所致胸主动脉环收缩。DOCA 盐型高血压大鼠表现内皮素受体的Bmax值和Kd 值升高 ;CPU0 2 1 4使清醒高血压大鼠的平均动脉压明显降低 ,在 6 0~ 90min时最为明显。结论 CPU0 2 1 4在正常大鼠竞争结合内皮素受体、拮抗血管收缩 ,在内皮素异常高血压大鼠可降低其血压 ,表明CPU0 2 1 AIM To determine the antagonistic activities of new endothelin receptor antagonist CPU0214 on the left ventricle membranes and the aorta ring contraction in normal rat and its reduction effect on the mean arterial pressure in conscious DOCA salt hypertensive rats. METHODS Left ventricle membranes of normal rat hearts achieved for competition binding assay was used to investigate the antagonistic effects of CPU0214. Aorta ring contraction induced by ET 1 in normal rat was used to investigate the antagonistic activity of CPU0214. DOCA salt hypertensive rats were induced by injection of deoxycorticosterone acetate (DOCA, sc) following with 1% NaCl as drinking for 4 wk. A multiple physiological recorder was used to record the mean arterial pressure of femoral artery. The endothelin receptor change in the left ventricle membranes of DOCA salt hypertensive rat was measured by binding assays. Intraperitoneal injection of CPU0214 was used to investigate its effect on reduction of mean arterial pressure. RESULTS In the left ventricle the IC 50 of endothelin receptor antagonist CPU0214 is 16 nmol·L -1 and CPU0214 (10 μmol·L -1 ) inhibited the ET 1 induced isolated aorta rings contraction in normal rats. Mean arterial pressure as well as B max and K d of left ventricle were increased significantly in DOCA salt hypertensive rat. CPU0214 (60 mg·kg -1 ip) significantly reduced the mean arterial pressure of conscious DOCA salt hypertensive rats especially during 60~90 min after administration. CONCLUSIONS CPU0214 has significantly antagonistic effects on the left ventricle membrane and the isolated aorta ring contraction in normal rat, which is verified by CPU0214 as a strong endothelin receptor antagonist. Furthermore its effect on the mean blood pressure reduction in conscious DOCA salt hypertensive rats, which is manifested as an abnormal endothelin system, shows its prosperity of drug development value as a new endothelin receptor antagonist.
出处 《中国药理学通报》 CAS CSCD 北大核心 2004年第4期409-413,共5页 Chinese Pharmacological Bulletin
基金 国家自然科学基金重点资助课题 No 3 0 2 3 0 170 3 0 1710 78
关键词 高血压 内皮素受体 内皮素受体拮抗剂 放射受体 结合 平均动脉压 hypertension endothelin receptor endothelin receptor antagonist binding assay mean arterial pressure
  • 相关文献

参考文献1

二级参考文献1

共引文献4

同被引文献19

  • 1戴德哉,吉民,黄敏,刘立钢.内皮素受体拮抗剂CPU0213的生物活性及抑制ETA及ETB受体的作用(英文)[J].中国药科大学学报,2004,35(6):552-557. 被引量:10
  • 2油红文,陈曦,油红捷,张宇清,蔡艳,刘国仗.内皮素及其受体对心脏细胞肥大与增殖的作用[J].中国医学科学院学报,2006,28(4):520-523. 被引量:20
  • 3Luft F C,Grim C E,Willis L R,et al.Natriuretic response to saline infusion in normotensive and hypertensive man[J].Circulation,1977,55(5):779-84.
  • 4Badyal D K,Dadhich A P,Lata H.Animal models of hypertension and effect of drugs[J].Indian J Pharmacol,2003,35(6):349-62.
  • 5Erdely A,Freshour G,Tain Y L,et al.DOCA/NaCl-induced chronic kidney disease:a comparison of renal nitric oxide production in resistant and susceptible rat strains[J].Am J Physiol Renal Physiol,2007,292(1):F192-6.
  • 6Morris R C Jr,Sebastian A,Forman A,et al.Normotensive salt sensitivity:effects of race and dietary potassium[J].Hypertension,1999,33(1):18-23.
  • 7Barba G,Cappuccio F P,Russo L,et al.Renal function and blood pressure response to dietary salt restriction in normotensive men[J].Hypertension,1996,27(5):1160-4.
  • 8蒋青松,黄燮南,周岐新.钙调神经磷酸酶在L-精氨酸抗心肌肥厚中的作用[J].中国药理学通报,2007,23(9):1218-1223. 被引量:9
  • 9YANAGISAWA M,KURIHARA H,KIMURA S,et al.A novel potent vasoconstrictor peptide produced by vascular endothelin cells[J].Nature,1988,332(61-63):411 -415.
  • 10袁盛华,戴德哉.内皮素受体拮抗剂治疗心衰[M]//彭司勋.药物化学进展(4).北京:化学工业出版社,2005:43-54.

引证文献3

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部